Facebook
Twitter
Telegram
Report an ErrorGeoVax Labs Balance Sheet 2011-2024 | GOVX
Annual Balance Sheet GeoVax Labs
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -9.69 M | -244 K | 40.3 K | -313 K | -454 K | -1.06 M | -1.02 M | -2.45 M | -907 K | -491 K |
Long Term Debt |
- | - | - | 14.7 K | 27.2 K | 39.6 K | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 14.7 K | 27.2 K | 39.6 K | - | - | - | - | - | - | - |
Total Current Liabilities |
3.52 M | 4.75 M | 5.44 M | 810 K | 2.02 M | 1.62 M | 811 K | 370 K | 127 K | 187 K | 312 K | 327 K | 942 K |
Total Liabilities |
- | - | 7.44 M | 825 K | 2.04 M | 1.66 M | 811 K | 370 K | 127 K | 187 K | 312 K | 327 K | 942 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-104 M | -78.4 M | -64.4 M | -45.8 M | -42.8 M | -40.5 M | -37.9 M | -35.7 M | -32.5 M | - | - | - | - |
Total Assets |
9.28 M | 31.3 M | 11.8 M | 10.4 M | 469 K | 642 K | 490 K | 610 K | 1.33 M | 1.33 M | 2.84 M | 1.48 M | 1.65 M |
Cash and Cash Equivalents |
6.45 M | 27.6 M | 11.4 M | 9.88 M | 283 K | 260 K | 313 K | 454 K | 1.06 M | 1.1 M | 2.51 M | 1.04 M | 1.17 M |
Book Value |
9.28 M | 31.3 M | 4.36 M | 9.57 M | -1.57 M | -1.02 M | -321 K | 240 K | 1.2 M | 1.15 M | 2.53 M | 1.15 M | 704 K |
Total Shareholders Equity |
5.76 M | 26.6 M | 4.36 M | 9.57 M | -1.57 M | -1.02 M | -321 K | 240 K | 1.2 M | 1.15 M | 2.53 M | 1.15 M | 704 K |
All numbers in USD currency
Quarterly Balance Sheet GeoVax Labs
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | 6.79 M | - | 5.5 M | 7.44 M | 336 K | 359 K | 464 K | 825 K | 825 K | 825 K | 825 K | 2.04 M | 2.04 M | 2.04 M | 2.04 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | 811 K | 811 K | 811 K | 811 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-110 M | -104 M | -96.8 M | -88.4 M | -82.4 M | -78.4 M | -73 M | - | -66.8 M | -64.4 M | -50.6 M | -48.7 M | -47.4 M | -45.8 M | -45.8 M | -45.8 M | -45.8 M | -42.8 M | -42.8 M | -42.8 M | -42.8 M | -40.5 M | -40.5 M | -40.5 M | -40.5 M | -37.9 M | -37.9 M | -37.9 M | -37.9 M | -35.7 M | -35.7 M | -35.7 M | -35.7 M | -32.5 M | -32.5 M | -32.5 M | -32.5 M | -29.8 M | -29.8 M | -29.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
3.36 M | 9.28 M | 16.2 M | 21.2 M | 27.4 M | 31.3 M | 38.6 M | - | 16.9 M | 11.8 M | 18.3 M | 19.8 M | 21.1 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 469 K | 469 K | 469 K | 469 K | 642 K | 642 K | 642 K | 642 K | 490 K | 490 K | 490 K | 490 K | 610 K | 610 K | 610 K | 610 K | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 2.84 M | 2.84 M | 2.84 M | 2.84 M | 1.48 M | 1.48 M | 1.48 M | 1.48 M | 1.65 M | 1.65 M | 1.65 M | 1.65 M |
Cash and Cash Equivalents |
769 K | 6.45 M | 12.7 M | 17.8 M | 23.8 M | 27.6 M | 34.7 M | - | 16.3 M | 11.4 M | 18.1 M | 19.5 M | 20.8 M | 9.88 M | 9.88 M | 9.88 M | 9.88 M | 283 K | 283 K | 283 K | 283 K | 260 K | 260 K | 260 K | 260 K | 313 K | 313 K | 313 K | 313 K | 454 K | 454 K | 454 K | 454 K | 1.06 M | 1.06 M | 1.06 M | 1.06 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 2.51 M | 2.51 M | 2.51 M | 2.51 M | 1.04 M | 1.04 M | 1.04 M | 1.04 M | 1.17 M | 1.17 M | 1.17 M | 1.17 M |
Book Value |
- | - | - | - | - | 31.3 M | 31.8 M | - | 11.4 M | 4.36 M | 18 M | 19.5 M | 20.7 M | 9.57 M | 9.57 M | 9.57 M | 9.57 M | -1.57 M | -1.57 M | -1.57 M | -1.57 M | -1.02 M | -1.02 M | -1.02 M | -1.02 M | -321 K | -321 K | -321 K | -321 K | 610 K | 610 K | 610 K | 610 K | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 2.84 M | 2.84 M | 2.84 M | 2.84 M | 1.48 M | 1.48 M | 1.48 M | 1.48 M | 1.65 M | 1.65 M | 1.65 M | 1.65 M |
Total Shareholders Equity |
54.3 K | 5.76 M | 9.12 M | 17.2 M | 22.9 M | 26.6 M | 31.8 M | 27.9 M | 11.4 M | 4.36 M | 18 M | 19.5 M | 20.7 M | 9.57 M | 9.57 M | 9.57 M | 9.57 M | -1.57 M | -1.57 M | -1.57 M | -1.57 M | -1.02 M | -1.02 M | -1.02 M | -1.02 M | -321 K | -321 K | -321 K | -321 K | 240 K | 240 K | 240 K | 240 K | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.15 M | 1.15 M | 1.15 M | 1.15 M | 2.53 M | 2.53 M | 2.53 M | 2.53 M | 1.15 M | 1.15 M | 1.15 M | 1.15 M | 704 K | 704 K | 704 K | 704 K |
All numbers in USD currency